Safety and Effectiveness of TactiCath™ Contact Force, Sensor Enabled™ (TactiCath SE) Catheter for Ablation of Drug Refractory, Symptomatic, Persistent Atrial Fibrillation (PERSIST-END IDE)
Phase: NA
Conditions: Persistent Atrial Fibrillation
Sponsor: Abbott Medical Devices

 
Clinical Investigation Plan Cover Page 
 
 
 
 
87173 CIP Posting Cover Page Ver C 
Template 
Page 1 of 1 
 
NCT Number: NCT03650556 
PERSIST-END Trial 
Safety and Effectiveness of TactiCath™ Contact Force, Sensor Enabled™ (TactiCath SE) Catheter for 
Ablation of Drug Refractory, Symptomatic, Persistent Atrial Fibrillation 
Study Document No: ABT-CIP-10239 
Version D 
Date: 14 JAN 2019 
 
 
Sponsor  
 
 
Abbott 
        
 
 
 
5050 Nathan Lane N 
      
  
 
 
Plymouth, MN 55442 
        
 
 
 
USA